arginine has been researched along with Cognition Disorders in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.70) | 18.7374 |
| 1990's | 3 (8.11) | 18.2507 |
| 2000's | 12 (32.43) | 29.6817 |
| 2010's | 21 (56.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baglieri, A; Bramanti, P; Calabro, RS; Furnari, A; Gervasi, G; Marino, S | 1 |
| Ballhausen, D; Baumgartner, MR; Beblo, S; Burgard, P; Das, A; Gautschi, M; Glahn, EM; Grünert, SC; Häberle, J; Hennermann, J; Hochuli, M; Huemer, M; Karall, D; Kölker, S; Lachmann, RH; Lindner, M; Lotz-Havla, A; Möslinger, D; Nuoffer, JM; Plecko, B; Rüegger, CM; Rutsch, F; Santer, R; Spiekerkoetter, U; Staufner, C; Stricker, T; Wijburg, FA; Williams, M | 1 |
| Kumar, A; Rinwa, P | 1 |
| Dhar, H; Kumar, A; Rinwa, P | 1 |
| Cedazo-Mínguez, Á; Cifuentes, A; Ibáñez, C; Lodeiro, M; Simó, C | 1 |
| Gordh, T; Grönbladh, A; Nyberg, F; Ortiz-Nieto, F; Raininko, R; Rhodin, A; Skottheim, B; von Ehren, M | 1 |
| Aboulkassim, T; Hamel, E; Imboden, H; Lecrux, C; Nicolakakis, N; Ongali, B; Papadopoulos, P; Rosa-Neto, P; Tong, XK | 1 |
| Barandiaran, M; Bergareche, A; Estanga, A; Gorostidi, A; Lopez de Munain, A; Marti-Masso, JF; Mondragon, E; Rodriguez-Oroz, MC; Ruiz-Martinez, J | 1 |
| Fan, Y; Gao, Q; Ma, L; Mu, LY; Song, ZQ; Zhang, YN | 1 |
| Chen, HB; Hu, MR; Wei, B; Xiong, JW; Yan, K; Yang, YJ; Yu, B; Zhan, JQ; Zhao, Y | 1 |
| Czarnecka, A; Milewski, K; Zielińska, M | 1 |
| Cens, T; Charnet, P; Leyris, JP | 1 |
| Arlt, S; Böger, RH; Eichenlaub, M; Jahn, H; Lehmbeck, JT; Maas, R; Schulze, F; Schwedhelm, E | 1 |
| Guerrant, RL; Lima, AA; Moore, SR; Oriá, MO; Oriá, RB | 1 |
| Amin, HJ; Sauve, RS; Soraisham, AS | 1 |
| Kumar, A; Kumar, P | 1 |
| Castañón, B; Casteleiro, N; Devesa, A; Devesa, J; Otero, A; Otero-Cepeda, XL; Quintana, A; Reimunde, P; Vilarnovo, Z | 1 |
| Chopra, K; Kuhad, A; Misra, S; Tiwari, V | 1 |
| Afenjar, A; Barbier, V; Boddaert, N; Chabli, A; Cheillan, D; de Keyzer, Y; de Lonlay, P; Desguerre, I; Jakobs, C; Mazzuca, M; Munnich, A; Philippe, A; Salomons, GS; Valayannopoulos, V | 1 |
| Brouwers, N; Funamoto, S; Ihara, Y; Iwata, N; Matsuba, Y; Mihira, N; Nilsson, P; Nishimura, M; Saido, TC; Saito, T; Sleegers, K; Suemoto, T; Takano, J; Van Broeckhoven, C; Yamada, K | 1 |
| Cauley, JA; Harris, T; Launer, L; Lindquist, K; Rosano, C; Satterfield, S; Schwartz, AV; Simonsick, EM; Vitartas, C; Vittinghoff, E; Yaffe, K | 1 |
| Erez, A; Lee, B; Nagamani, SC | 1 |
| Chen, B; Cheng, Q; Friedman, B; Lei, IF; Lyden, PD; Olson, ES; Pereira, B; Tsien, RY; Whitney, MA; Winkle, JA; Zhao, L | 1 |
| Ahluwalia, V; Bajaj, JS; Bouneva, I; Fuchs, M; Gilles, H; Heuman, DM; Kraft, KA; Luketic, V; Monteith, P; Noble, NA; Puri, P; Sanyal, AJ; Sterling, RK; Stravitz, RT; Wade, JB; White, MB | 1 |
| Araujo, JA; Bhatnagar, S; Burrows, J; de Rivera, C; Gore, A; Milgram, NW; Pan, Y | 1 |
| Blackman, JA; Buck, ML; Darring, JG; Deboer, MD; Gurka, MJ; Kuperminc, MN; Norwood, KW; Patrick, PD; Rogol, AD; Wamstad, JB | 1 |
| Arias, B; Barrantes-Vidal, N; Catalán, R; Fañanás, L; Guitart, M; Papiol, S; Salgado, P | 1 |
| Selley, ML | 1 |
| Birthelmer, A; Cassel, JC; Förstermann, U; Gödtel-Armbrust, U; Jackisch, R; Knörle, R; Lazaris, A; Schweizer, T | 1 |
| Boronow, J; Dickerson, F; Origoni, A; Stallings, C; Yolken, R | 1 |
| Busto, R; Dietrich, WD; Green, EJ; Prado, R; Stagliano, NE | 1 |
| Ampola, MG; Breen, JC; Prasad, AN; Rosman, NP | 1 |
| Balakrishnan, S; Pandhi, P | 1 |
| D'Hooge, R; De Deyn, PP; Marescau, B; Qureshi, IA | 1 |
| Barron, VJ; Burns, R; Thomas, DW | 1 |
| Bromberg, JE; Haaxma-Reiche, H; Harder, H; Holtel, H; Kluin-Nelemans, HC; Menten, J; Poortmans, P; van den Bent, MJ | 1 |
| Deelman, BG; Kamps, WA; Kingma, A; Mooyaart, EL; Van Dommelen, RI; Wilmink, JT | 1 |
4 review(s) available for arginine and Cognition Disorders
| Article | Year |
|---|---|
Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?
Topics: Animals; Arginine; Brain; Cognition Disorders; Endothelium, Vascular; Hepatic Encephalopathy; Humans; Inflammation; Nitric Oxide Synthase; Nitrosation; Oxidative Stress | 2017 |
Malnutrition as an enteric infectious disease with long-term effects on child development.
Topics: Animals; Arginine; Child Nutrition Disorders; Child, Preschool; Cognition Disorders; Diarrhea; Female; Fluid Therapy; Glutamine; Growth Disorders; Humans; Infant; Infections; Intestinal Diseases; Intestinal Diseases, Parasitic; Randomized Controlled Trials as Topic | 2008 |
Argininosuccinate lyase deficiency.
Topics: Arginine; Argininosuccinate Lyase; Argininosuccinic Acid; Argininosuccinic Aciduria; Child, Preschool; Citrulline; Cognition Disorders; Diet, Protein-Restricted; Fumarates; Genetic Testing; Glucose; Humans; Hyperammonemia; Hypertension; Infant; Infant, Newborn; Lipids; Liver Diseases; Liver Transplantation; Neonatal Screening; Phenylbutyrates; Sodium Benzoate | 2012 |
Argininemia: a treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: case reports and literature review.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Amino Acids, Essential; Arginase; Arginine; Atrophy; Cerebellum; Cerebral Cortex; Cerebral Palsy; Child; Child, Preschool; Cognition Disorders; Dietary Proteins; Disease Progression; Fatal Outcome; Female; Follow-Up Studies; Humans; Hyperargininemia; Male; Microcephaly; Models, Neurological; Muscle Spasticity; Neurodegenerative Diseases; Seizures; Treatment Outcome; Vomiting | 1997 |
2 trial(s) available for arginine and Cognition Disorders
| Article | Year |
|---|---|
Is high oral dose L-arginine intake effective in leukoaraiosis? Preliminary data, study protocol and expert's opinion.
Topics: Administration, Oral; Aged; Arginine; Cognition Disorders; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gait; Humans; Leukoaraiosis; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Outcome Assessment, Health Care; Prospective Studies; Treatment Outcome | 2013 |
Neurodevelopmental outcomes of premature infants treated with l-arginine for prevention of necrotising enterocolitis.
Topics: Alberta; Arginine; Blindness; Cerebral Palsy; Child, Preschool; Cognition Disorders; Deafness; Developmental Disabilities; Enterocolitis, Necrotizing; Female; Follow-Up Studies; Humans; Infant, Newborn; Male; Premature Birth; Treatment Outcome | 2009 |
31 other study(ies) available for arginine and Cognition Disorders
| Article | Year |
|---|---|
Cross-sectional observational study of 208 patients with non-classical urea cycle disorders.
Topics: Adolescent; Adult; Age of Onset; Aged; Arginine; Child; Child, Preschool; Citrulline; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Diet Therapy; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neonatal Screening; Ornithine Carbamoyltransferase Deficiency Disease; Time Factors; Treatment Outcome; Urea Cycle Disorders, Inborn; Young Adult | 2014 |
Modulation of nitrergic signalling pathway by American ginseng attenuates chronic unpredictable stress-induced cognitive impairment, neuroinflammation, and biochemical alterations.
Topics: Acetylcholinesterase; Animals; Arginine; Behavior, Animal; Catalase; Cognition Disorders; Corticosterone; Encephalitis; Glutathione; Hippocampus; Male; Mice; NADH Dehydrogenase; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrites; Panax; Plant Extracts; Signal Transduction; Stress, Physiological; Stress, Psychological; Succinate Dehydrogenase; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2014 |
Possible nitric oxide modulation in the protective effects of rutin against experimental head trauma-induced cognitive deficits: behavioral, biochemical, and molecular correlates.
Topics: Acetylcholinesterase; Animals; Arginine; Brain; Caspase 3; Catalase; Cell Death; Cognition Disorders; Craniocerebral Trauma; Drug Evaluation, Preclinical; Glutathione; Lipid Peroxidation; Male; Maze Learning; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Random Allocation; Rats; Rats, Wistar; Rutin; Tumor Necrosis Factor-alpha | 2014 |
Decreased cerebrospinal fluid levels of L-carnitine in non-apolipoprotein E4 carriers at early stages of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Arginine; Biomarkers; Carnitine; Cognition Disorders; Cognitive Dysfunction; Creatine; Dicarboxylic Acids; Female; Glycine; Heterozygote; Humans; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Sensitivity and Specificity; tau Proteins | 2014 |
Recombinant human growth hormone improves cognitive capacity in a pain patient exposed to chronic opioids.
Topics: Apoptosis; Arginine; Aspartic Acid; Cognition Disorders; Creatine; Growth Hormone; Growth Hormone-Releasing Hormone; Hippocampus; Hormone Replacement Therapy; Human Growth Hormone; Humans; Intraoperative Complications; Kidney; Male; Methadone; Middle Aged; Narcotics; Neuralgia; Neurogenesis; Peripheral Nerve Injuries; Proton Magnetic Resonance Spectroscopy; Quality of Life | 2014 |
Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Angiotensin II Type 1 Receptor Blockers; Animals; Arginine; Blood Pressure; Brain; Cerebrovascular Circulation; Cognition Disorders; Disease Models, Animal; Endothelin-1; Enzyme Inhibitors; Female; Gene Expression Regulation; Humans; Losartan; Male; Mice; Mice, Transgenic; Mutation | 2014 |
Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Case-Control Studies; Cognition Disorders; Female; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Neuropsychological Tests; Parkinson Disease; Protein Serine-Threonine Kinases; Severity of Illness Index | 2014 |
S100B and ADMA in cerebral small vessel disease and cognitive dysfunction.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Cerebral Small Vessel Diseases; Cognition Disorders; Female; Humans; Male; Middle Aged; S100 Calcium Binding Protein beta Subunit; Single-Blind Method | 2015 |
Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia.
Topics: Adult; Arginine; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Female; Humans; Male; Neuropsychological Tests; Schizophrenia; Young Adult | 2016 |
Introduction into Ca(v)2.1 of the homologous mutation of Ca(v)1.2 causing the Timothy syndrome questions the role of V421 in the phenotypic definition of P-type Ca(2+) channel.
Topics: Alanine; Animals; Arginine; Arrhythmias, Cardiac; Calcium; Calcium Channels, L-Type; Calcium Channels, N-Type; Calcium Channels, R-Type; Cation Transport Proteins; Cognition Disorders; Genotype; Glutamic Acid; Glycine; GTP-Binding Proteins; Ion Channel Gating; Kinetics; Membrane Potentials; Mutation; Phenotype; Rats; Syndrome; Valine; Xenopus | 2008 |
Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Arginine; Biomarkers; Body Mass Index; Case-Control Studies; Cognition Disorders; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Risk Factors | 2008 |
Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Arginine; Behavior, Animal; Brain; Cognition Disorders; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Glutathione; Glutathione Transferase; Male; Maze Learning; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar; Tacrolimus; Time Factors | 2009 |
Effects of growth hormone (GH) replacement and cognitive rehabilitation in patients with cognitive disorders after traumatic brain injury.
Topics: Arginine; Blood-Brain Barrier; Brain Injuries; Cognition Disorders; Combined Modality Therapy; Female; Hormone Replacement Therapy; Human Growth Hormone; Humans; Male; Middle Aged; Neural Pathways; Neuropsychological Tests | 2011 |
Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin administered rats.
Topics: Acetylcholinesterase; Animals; Antioxidants; Arginine; Behavior, Animal; Benzodioxoles; Cognition Disorders; Drug Administration Routes; Drug Interactions; Enzyme Inhibitors; Female; Lipid Peroxidation; Maze Learning; Motor Activity; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phenols; Rats; Rats, Wistar; Signal Transduction; Streptozocin; Stress, Physiological; Tumor Necrosis Factor-alpha | 2011 |
Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect.
Topics: Administration, Oral; Adolescent; Amino Acid Transport Disorders, Inborn; Arginine; Child; Child, Preschool; Cognition Disorders; Creatine; Female; Glycine; Humans; Intellectual Disability; Magnetic Resonance Spectroscopy; Male; Membrane Transport Proteins; Nerve Tissue Proteins; Plasma Membrane Neurotransmitter Transport Proteins | 2012 |
Potent amyloidogenicity and pathogenicity of Aβ43.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Arginine; Cell Line, Tumor; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Embryo, Mammalian; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Humans; Immunoprecipitation; Isoleucine; L-Lactate Dehydrogenase; Male; Maze Learning; Memory, Short-Term; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Mutation; Neuroblastoma; Neurons; Peptide Fragments; Presenilin-1 | 2011 |
Advanced glycation end product level, diabetes, and accelerated cognitive aging.
Topics: Aged; Aging; Arginine; Chi-Square Distribution; Cognition Disorders; Diabetes Mellitus; Female; Glycation End Products, Advanced; Humans; Longitudinal Studies; Lysine; Male; Mental Status Schedule; Neuropsychological Tests; Odds Ratio | 2011 |
Thrombin activity associated with neuronal damage during acute focal ischemia.
Topics: Amino Acids; Analysis of Variance; Animals; Antithrombins; Arginine; Avoidance Learning; Brain Injuries; Cell Death; Cognition Disorders; Disease Models, Animal; Factor X; Fibrinolysin; Gene Expression Regulation; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; Maze Learning; Motor Activity; Nerve Tissue Proteins; Pipecolic Acids; Pyrroles; Rats; Reaction Time; Receptor, PAR-1; Sulfonamides; Thrombin; Time Factors | 2012 |
Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis.
Topics: Adult; Arginine; Aspartic Acid; Biomarkers; Brain; Cognition Disorders; Cross-Sectional Studies; Female; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Inositol; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prospective Studies | 2013 |
Cognitive enhancement in middle-aged and old cats with dietary supplementation with a nutrient blend containing fish oil, B vitamins, antioxidants and arginine.
Topics: Age Factors; Animals; Antioxidants; Arginine; Brain; Cats; Cognition; Cognition Disorders; Dementia; Dietary Fats; Dietary Supplements; Discrimination, Psychological; Fish Oils; Learning; Memory; Mental Processes; Micronutrients; Risk Factors; Vitamin B Complex | 2013 |
Neuropsychological recovery and quality-of-life in children and adolescents with growth hormone deficiency following TBI: a preliminary study.
Topics: Adolescent; Arginine; Brain Injuries; Child; Cognition Disorders; Female; Follow-Up Studies; Glucagon; Hormones; Human Growth Hormone; Humans; Male; Pituitary Gland; Predictive Value of Tests; Prospective Studies; Quality of Life; Recovery of Function; Young Adult | 2013 |
Analysis of polymorphisms at the tumor suppressor gene p53 (TP53) in contributing to the risk for schizophrenia and its associated neurocognitive deficits.
Topics: Adult; Alleles; Arginine; Chi-Square Distribution; Cognition Disorders; DNA Transposable Elements; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Polymorphism, Genetic; Proline; Risk; Schizophrenia; Tumor Suppressor Protein p53 | 2004 |
Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
Topics: Alzheimer Disease; Amidohydrolases; Animals; Antioxidants; Arginine; Brain; Cells, Cultured; Cognition Disorders; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Feedback, Physiological; Homocysteine; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Proline; Rats; Thiocarbamates; Up-Regulation | 2004 |
Cognitive deficits in aged rats correlate with levels of L-arginine, not with nNOS expression or 3,4-DAP-evoked transmitter release in the frontoparietal cortex.
Topics: 4-Aminopyridine; Acetylcholine; Aging; Amifampridine; Animals; Arginine; Cerebral Cortex; Cognition Disorders; Female; Frontal Lobe; Gene Expression Regulation; Nerve Tissue Proteins; Neurotransmitter Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Norepinephrine; Parietal Lobe; Rats; Rats, Long-Evans; Serotonin | 2005 |
The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia.
Topics: Adult; Antibodies, Viral; Arginine; Bipolar Disorder; Cognition Disorders; Cysteine; Female; Genetic Predisposition to Disease; Genotype; Herpesvirus 1, Human; Humans; Intelligence; Lymphotoxin-alpha; Male; Middle Aged; Neuropsychological Tests; Polymorphism, Genetic; Schizophrenia | 2007 |
The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat.
Topics: Animals; Arginine; Behavior, Animal; Blood Pressure; Cerebrovascular Disorders; Citrulline; Cognition Disorders; Enzyme Inhibitors; Intracranial Embolism and Thrombosis; Male; Motor Cortex; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Somatosensory Cortex; Thromboembolism | 1997 |
Cognitive dysfunction induced by phenytoin and valproate in rats: effect of nitric oxide.
Topics: Animals; Anticonvulsants; Arginine; Cognition Disorders; Enzyme Inhibitors; Female; Male; Memory; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroarginine; Phenytoin; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Valproic Acid | 1999 |
Impaired cognitive performance in ornithine transcarbamylase-deficient mice on arginine-free diet.
Topics: Ammonia; Animals; Arginine; Avoidance Learning; Cognition Disorders; Diet; Maze Learning; Mice; Mice, Mutant Strains; Ornithine Carbamoyltransferase Deficiency Disease; Reference Values; Retention, Psychology; Swimming | 2000 |
Reversible encephalopathy possibly associated with bismuth subgallate ingestion.
Topics: Adult; Aged; Alanine; Arginine; Bismuth; Brain Diseases; Cerebellum; Chromatography; Cognition Disorders; Colonic Neoplasms; Colostomy; Female; Hallucinations; Humans; Libido; Male; Middle Aged; Myoclonus; Purkinje Cells; Tremor | 1974 |
Cognitive status and quality of life after treatment for primary CNS lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Carmustine; Case-Control Studies; Central Nervous System Neoplasms; Cognition Disorders; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Humans; Hydrocortisone; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelin Sheath; Neuropsychological Tests; Prospective Studies; Quality of Life; Teniposide | 2004 |
No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Attention; Child, Preschool; Cognition Disorders; Cyclophosphamide; Cytarabine; Dexamethasone; Female; Follow-Up Studies; Humans; Ifosfamide; Injections, Spinal; Learning Disabilities; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Netherlands; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Survivors; Teniposide; Treatment Outcome; Vincristine | 2002 |